Correlation Between Apellis Pharmaceuticals and Immunovant
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Immunovant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Immunovant into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Immunovant, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Immunovant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Immunovant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Immunovant.
Diversification Opportunities for Apellis Pharmaceuticals and Immunovant
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Apellis and Immunovant is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Immunovant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovant and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Immunovant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovant has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Immunovant go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Immunovant
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.37 times more return on investment than Immunovant. However, Apellis Pharmaceuticals is 1.37 times more volatile than Immunovant. It trades about 0.14 of its potential returns per unit of risk. Immunovant is currently generating about -0.16 per unit of risk. If you would invest 2,698 in Apellis Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 301.50 from holding Apellis Pharmaceuticals or generate 11.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Immunovant
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Immunovant |
Apellis Pharmaceuticals and Immunovant Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Immunovant
The main advantage of trading using opposite Apellis Pharmaceuticals and Immunovant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Immunovant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovant will offset losses from the drop in Immunovant's long position.| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
| Immunovant vs. Arbutus Biopharma Corp | Immunovant vs. Arcutis Biotherapeutics | Immunovant vs. Legend Biotech Corp | Immunovant vs. Protagonist Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |